DataKnowledgeCloudtrainingcoordination

Acute lymphocytic leukemia (Disease Or Phenotype)

Omim:MTHU067958

Nci:C3167

Mondo:MONDO:35605

Medcin:MEDCIN:31478

Mdr:MDR:10025305

Id:bd555543-6253-5be7-9d01-728af7e0171d

Icpc2icd10eng:MTHU046612

Icd10cm:C91.0

Efo:EFO:220

Doid:DOID:9952

Chv:CHV:56422

Results found

Linked to

	Label	Description
	Dexamethasone indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Vincristine indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Betamethasone acetate indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Mercaptopurine indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)- indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	betamethasone indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Acute lymphocytic leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dexamethasone indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Vincristine indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Betamethasone acetate indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Mercaptopurine indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)- indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Acute lymphocytic leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.